51 Lakh people in India are at risk of contracting Chikungunya in the Long Term: Study

Written By :  Anshika Mishra
Published On 2025-10-04 11:51 GMT   |   Update On 2025-10-04 11:51 GMT
Advertisement

India is projected to face the most significant long-term impact of chikungunya, with an estimated 51 lakh people at risk annually, according to a global modelling study published in BMJ Global Health. Brazil and Indonesia follow as the second and third most affected countries, with India and Brazil together accounting for 48% of the global healthcare and individual burden. Researchers from the London School of Hygiene and Tropical Medicine highlight chronic health effects as the major concern, with about half of those infected potentially suffering long-term disabilities.

Advertisement

Globally, over 1.4 crore people could be at risk yearly, predominantly children under 10 and adults over 80. Chikungunya is transmitted by Aedes mosquitoes, causing fever, severe joint pain, and in many cases, prolonged disability. With no specific treatments, two vaccines are approved in some countries, including the US. The study emphasizes urgent public health preparedness and targeting vulnerable populations for vaccination to mitigate this growing threat.

REFERENCE: Kang H, Lim A, Auzenbergs M, Clark A, Colón-González FJ, Salje H, et al. Global, regional and national burden of chikungunya: force of infection mapping and spatial modelling study. BMJ Global Health. 2025;10:e018598. https://doi.org/10.1136/bmjgh-2024-018598

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News